EUVIMEDEUVIMED entdecken
Crossref

Carrier frequency and incidence estimation of deficiency of adenosine deaminase 2 in the Chinese population based on massive exome sequencing data

Lulu Yan, Xiangwei Sun, Biying Lou, Yuxin Zhang, Danyan Zhuang, Jia Jia, Li Zhang, Yan He, Limin Xu, Shanshan Wu, Qing Zhou, Changshui Chen und 2 weitere

Clinical Immunology · 2024

DOI: 10.1016/j.clim.2024.110394 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Immunology, 2024. Verfasst von Lulu Yan und 13 weiteren Autor:innen. Beteiligte Einrichtung: The Central Laboratory of Birth Defects Prevention and Control, The Affiliated Women and Children's Hospital of Ningbo University, Ningbo, China; Nin…. Hauptthemen laut MEDLINE: Adenosine Deaminase, Exome Sequencing, Gene Frequency. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 55 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Deficiency of adenosine deaminase 2 (DADA2) is an autosomal recessive autoinflammatory disease characterised by early onset stroke, recurrent fever, and diverse vascular pathologies, caused by loss-of-function homozygous or compound heterozygous variants of ADA2. This research aimed to determine the carrier frequency and expected incidence of DADA2 in China, using massive exome sequencing (ES) data. A total of 50 likely pathogenic/pathogenic variants (LP/PVs) were identified among 69,413 Chinese individuals, including 20 novel and rare variants (

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adenosine DeaminaseExome SequencingGene FrequencyHumansChinaIncidenceIntercellular Signaling Peptides and ProteinsHeterozygoteMutationFemaleMaleEast Asian PeopleHereditary Autoinflammatory Diseases

Stichwörter der Autor:innen

ADA2 variantCarrier frequency incidenceDeficiency of adenosine deaminase 2Exome screening

Substanzen

Adenosine DeaminaseADA2 protein, humanIntercellular Signaling Peptides and Proteins

Autor:innen und Institutionen

  • The Central Laboratory of Birth Defects Prevention and Control, The Affiliated Women and Children's Hospital of Ningbo University, Ningbo, China; Ningbo Key Laboratory for the Prevention and Treatment of Embryogenic Dis…
  • Liangzhu Laboratory, Zhejiang University, Hangzhou, China.
  • Department of Pediatrics, Jinhua Maternal and Child Health Care Hospital, Jinhua, China.
  • Fujun Genetics Biotechnology Co., LTD, Shanghai, China.
  • Department of Pediatrics, The Affiliated Women and Children's Hospital of Ningbo University, Ningbo, China.
  • Ningbo Key Laboratory of Genomic Medicine and Birth Defects Prevention, The Affiliated Women and Children's Hospital of Ningbo University, Ningbo, China; Paediatric Surgery Centre, The Affiliated Women and Children's Ho…

Zitieren

APA

Yan, L., Sun, X., Lou, B., Zhang, Y., Zhuang, D., Jia, J., Zhang, L., He, Y., Xu, L., Wu, S., Zhou, Q., Chen, C., Yu, X., & Li, H. (2024). Carrier frequency and incidence estimation of deficiency of adenosine deaminase 2 in the Chinese population based on massive exome sequencing data. Clinical Immunology. https://doi.org/10.1016/j.clim.2024.110394

Vancouver

Yan L, Sun X, Lou B, Zhang Y, Zhuang D, Jia J, et al. Carrier frequency and incidence estimation of deficiency of adenosine deaminase 2 in the Chinese population based on massive exome sequencing data. Clinical Immunology. 2024. doi:10.1016/j.clim.2024.110394

BibTeX
@article{Yan2024,
  author = {Yan, Lulu and Sun, Xiangwei and Lou, Biying and Zhang, Yuxin and Zhuang, Danyan and Jia, Jia and Zhang, Li and He, Yan and Xu, Limin and Wu, Shanshan and Zhou, Qing and Chen, Changshui and Yu, Xiaomin and Li, Haibo},
  title = {Carrier frequency and incidence estimation of deficiency of adenosine deaminase 2 in the Chinese population based on massive exome sequencing data},
  journal = {Clinical Immunology},
  year = {2024},
  doi = {10.1016/j.clim.2024.110394}
}
Kostenlos starten →